DR REDDYS LABORATORIES
Back to Income Statement
|
DR REDDYS LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹5,578 Cr | ₹4,507 Cr | ₹2,183 Cr | ₹1,952 Cr | ₹2,026 Cr |
What is the latest Consolidated Net Profit of DR REDDYS LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹5,578 Cr |
| Mar2024 | ₹4,507 Cr |
| Mar2023 | ₹2,183 Cr |
| Mar2022 | ₹1,952 Cr |
| Mar2021 | ₹2,026 Cr |
How is Consolidated Net Profit of DR REDDYS LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,578 Cr | 23.75 | |
| Mar2024 | ₹4,507 Cr | 106.52 | |
| Mar2023 | ₹2,183 Cr | 11.83 | |
| Mar2022 | ₹1,952 Cr | -3.67 | |
| Mar2021 | ₹2,026 Cr | - | |
Compare Consolidated Net Profit of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹100,778.0 Cr | -3.8% | -3.1% | -8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,631.0 Cr | 1.9% | -0.8% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,111.0 Cr | 3.2% | 4.8% | 12.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,228.0 Cr | 6.3% | 8.9% | 15.8% | Stock Analytics | |
| CIPLA | ₹117,983.0 Cr | -3.3% | -2% | -1.6% | Stock Analytics | |
| MANKIND PHARMA | ₹93,157.7 Cr | 2.5% | 3.6% | -19.9% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -3.8% |
-3.1% |
-8% |
| SENSEX | -1.2% |
-1.1% |
6.3% |
You may also like the below Video Courses